XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Loans to Related Parties
Accumulated Deficit
Beginning balance (in shares) at Dec. 27, 2020   62,562,051 16,731,625      
Beginning balance at Dec. 27, 2020 $ (307,362) $ 505,638 $ 17 $ 19,662 $ (4,000) $ (323,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (30,045)         (30,045)
Exercise of stock options (in shares) 561,465   561,465      
Exercise of stock options $ 2,521   $ 1 2,520    
Stock-based compensation expense 1,224     1,224    
Issuance of preferred stock (net of issuance costs) (in shares)   6,669,146        
Issuance of preferred stock (net of issuance costs) 0 $ 108,858        
Ending balance (in shares) at Mar. 28, 2021   69,231,197 17,293,090      
Ending balance at Mar. 28, 2021 (333,662) $ 614,496 $ 18 23,406 $ (4,000) (353,086)
Beginning balance (in shares) at Dec. 26, 2021   0 109,345,697      
Beginning balance at Dec. 26, 2021 653,117 $ 0 $ 109 1,129,224   (476,216)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (49,200)         (49,200)
Exercise of stock options (in shares) 153,158   153,158      
Exercise of stock options $ 849   $ 1 848    
Issuance of common stock related to restricted shares (in shares)     12,500      
Stock-based compensation expense 22,165     22,165    
Ending balance (in shares) at Mar. 27, 2022   0 109,511,355      
Ending balance at Mar. 27, 2022 $ 626,931 $ 0 $ 110 $ 1,152,237   $ (525,416)